Suppr超能文献

图雷特综合征的D1CT - 7小鼠模型在对空间限制的反应中表现出感觉运动门控缺陷。

The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement.

作者信息

Godar Sean C, Mosher Laura J, Strathman Hunter J, Gochi Andrea M, Jones Cori M, Fowler Stephen C, Bortolato Marco

机构信息

Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS, USA.

Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA.

出版信息

Br J Pharmacol. 2016 Jul;173(13):2111-21. doi: 10.1111/bph.13243. Epub 2015 Aug 10.

Abstract

BACKGROUND AND PURPOSE

The D1CT-7 mouse is one of the best known animal models of Tourette syndrome (TS), featuring spontaneous tic-like behaviours sensitive to standard TS therapies; these characteristics ensure a high face and predictive validity of this model, yet its construct validity remains elusive. To address this issue, we studied the responses of D1CT-7 mice to two critical components of TS pathophysiology: the exacerbation of tic-like behaviours in response to stress and the presence of sensorimotor gating deficits, which are thought to reflect the perceptual alterations causing the tics.

EXPERIMENTAL APPROACH

D1CT-7 and wild-type (WT) littermates were subjected to a 20 min session of spatial confinement (SC) within an inescapable, 10 cm wide cylindrical enclosure. Changes in plasma corticosterone levels, tic-like behaviours and other spontaneous responses were measured. SC-exposed mice were also tested for the prepulse inhibition (PPI) of the startle response (a sensorimotor gating index) and other TS-related behaviours, including open-field locomotion, novel object exploration and social interaction and compared with non-confined counterparts.

KEY RESULTS

SC produced a marked increase in corticosterone concentrations in both D1CT-7 and WT mice. In D1CT-7, but not WT mice, SC exacerbated tic-like and digging behaviours, and triggered PPI deficits and aggressive responses. Conversely, SC did not modify locomotor activity or novel object exploration in D1CT-7 mice. Both tic-like behaviours and PPI impairments in SC-exposed D1CT-7 mice were inhibited by standard TS therapies and D1 dopamine receptor antagonism.

CONCLUSIONS AND IMPLICATIONS

These findings collectively support the translational and construct validity of D1CT-7 mice with respect to TS.

LINKED ARTICLES

This article is part of a themed section on Updating Neuropathology and Neuropharmacology of Monoaminergic Systems. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.13/issuetoc.

摘要

背景与目的

D1CT - 7小鼠是最著名的抽动秽语综合征(TS)动物模型之一,具有对标准TS疗法敏感的自发性抽动样行为;这些特征确保了该模型具有较高的表面效度和预测效度,但其结构效度仍不明确。为解决这一问题,我们研究了D1CT - 7小鼠对TS病理生理学两个关键组成部分的反应:应激引起的抽动样行为加剧以及感觉运动门控缺陷的存在,后者被认为反映了导致抽动的感知改变。

实验方法

将D1CT - 7小鼠和野生型(WT)同窝小鼠置于一个无法逃脱的、10厘米宽的圆柱形围栏内进行20分钟的空间限制(SC)实验。测量血浆皮质酮水平、抽动样行为和其他自发反应的变化。对经历SC的小鼠还进行惊吓反应的前脉冲抑制(PPI,一种感觉运动门控指标)以及其他与TS相关行为的测试,包括旷场运动、新物体探索和社交互动,并与未受限的对照小鼠进行比较。

主要结果

SC使D1CT - 7小鼠和WT小鼠的皮质酮浓度显著升高。在D1CT - 7小鼠而非WT小鼠中,SC加剧了抽动样行为和挖掘行为,并引发了PPI缺陷和攻击反应。相反,SC并未改变D

相似文献

1
The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement.
Br J Pharmacol. 2016 Jul;173(13):2111-21. doi: 10.1111/bph.13243. Epub 2015 Aug 10.
2
Assessment of gait and sensorimotor deficits in the D1CT-7 mouse model of Tourette syndrome.
J Neurosci Methods. 2017 Dec 1;292:37-44. doi: 10.1016/j.jneumeth.2017.01.009. Epub 2017 Jan 15.
3
Isoallopregnanolone reduces tic-like behaviours in the D1CT-7 mouse model of Tourette syndrome.
J Neuroendocrinol. 2020 Jan;32(1):e12754. doi: 10.1111/jne.12754. Epub 2019 Jun 7.
5
Behavioral fragmentation in the D1CT-7 mouse model of Tourette's syndrome.
CNS Neurosci Ther. 2018 Aug;24(8):703-711. doi: 10.1111/cns.12789. Epub 2018 Jan 3.
6
Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats.
Br J Pharmacol. 2016 Jul;173(13):2122-34. doi: 10.1111/bph.13232. Epub 2015 Jul 30.
9
Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.
Neurosci Biobehav Rev. 2013 Jul;37(6):1150-6. doi: 10.1016/j.neubiorev.2012.09.002. Epub 2012 Sep 24.
10
Tics: neurological disorders determined by a deficit in sensorimotor gating processes.
Neurol Sci. 2022 Oct;43(10):5839-5850. doi: 10.1007/s10072-022-06235-0. Epub 2022 Jul 4.

引用本文的文献

2
The role of neuroactive steroids in tic disorders.
Neurosci Biobehav Rev. 2024 May;160:105637. doi: 10.1016/j.neubiorev.2024.105637. Epub 2024 Mar 20.
3
The Dysfunctional Mechanisms Throwing Tics: Structural and Functional Changes in Tourette Syndrome.
Behav Sci (Basel). 2023 Aug 10;13(8):668. doi: 10.3390/bs13080668.
4
Prefrontal allopregnanolone mediates the adverse effects of acute stress in a mouse model of tic pathophysiology.
Neuropsychopharmacology. 2023 Aug;48(9):1288-1299. doi: 10.1038/s41386-023-01603-6. Epub 2023 May 17.
6
Neuroscience and actometry: An example of the benefits of the precise measurement of behavior.
Brain Res Bull. 2022 Jul;185:86-90. doi: 10.1016/j.brainresbull.2022.04.009. Epub 2022 Apr 25.
7
Recent progress on Tourette syndrome.
Fac Rev. 2021 Sep 7;10:70. doi: 10.12703/r/10-70. eCollection 2021.
8
Allopregnanolone: The missing link to explain the effects of stress on tic exacerbation?
J Neuroendocrinol. 2022 Feb;34(2):e13022. doi: 10.1111/jne.13022. Epub 2021 Aug 22.
10
Allopregnanolone is required for prepulse inhibition deficits induced by D dopamine receptor activation.
Psychoneuroendocrinology. 2019 Oct;108:53-61. doi: 10.1016/j.psyneuen.2019.06.009. Epub 2019 Jun 14.

本文引用的文献

1
Pediatric Tourette syndrome: insights from recent neuroimaging studies.
J Obsessive Compuls Relat Disord. 2014 Oct 1;3(4):386-393. doi: 10.1016/j.jocrd.2014.04.002.
2
Animal models of tic disorders: a translational perspective.
J Neurosci Methods. 2014 Dec 30;238:54-69. doi: 10.1016/j.jneumeth.2014.09.008. Epub 2014 Sep 20.
3
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.
Br J Pharmacol. 2013 Dec;170(8):1459-581. doi: 10.1111/bph.12445.
4
A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome.
Clin Neuropharmacol. 2014 Jan-Feb;37(1):26-30. doi: 10.1097/WNF.0000000000000017.
5
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.
Nucleic Acids Res. 2014 Jan;42(Database issue):D1098-106. doi: 10.1093/nar/gkt1143. Epub 2013 Nov 14.
6
Motor control, habits, complex motor stereotypies, and Tourette syndrome.
Ann N Y Acad Sci. 2013 Nov;1304:22-31. doi: 10.1111/nyas.12281. Epub 2013 Oct 31.
7
Repeated cortico-striatal stimulation generates persistent OCD-like behavior.
Science. 2013 Jun 7;340(6137):1234-9. doi: 10.1126/science.1234733.
8
Clinical assessment of Tourette syndrome and tic disorders.
Neurosci Biobehav Rev. 2013 Jul;37(6):997-1007. doi: 10.1016/j.neubiorev.2012.11.013. Epub 2012 Dec 1.
9
Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.
Psychoneuroendocrinology. 2013 Apr;38(4):542-51. doi: 10.1016/j.psyneuen.2012.07.014. Epub 2012 Aug 9.
10
NMDARs mediate the role of monoamine oxidase A in pathological aggression.
J Neurosci. 2012 Jun 20;32(25):8574-82. doi: 10.1523/JNEUROSCI.0225-12.2012.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验